Patent · US Active

Immunomodulator antibody drug conjugates and uses thereof

US11744876B2 · kind B2 · utility

2Cited by
1References
47Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2020
Grant dateSep 5, 2023
Priority date
Expiry dateJun 10, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/572
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, trifunctional antibody products thereof, and methods and pharmaceutical compositions for use in treatment of inflammatory and/or proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.